Liposomal daunorubicin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Liposomal daunorubicin, covering 2013-01-23 to 2014-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer [Phase 1]